<DOC>
	<DOCNO>NCT01814462</DOCNO>
	<brief_summary>The present study aim document ass change single parameter pulse wave analysis ( ASI single parameter ) well evaluate ASI cardiovascular risk assessment initiation CPAP therapy 6 month CPAP therapy patient obstructive sleep apnea .</brief_summary>
	<brief_title>Impact CPAP Therapy Obstructive Sleep Apnea Parameters Nocturnal Pulse Wave Analysis</brief_title>
	<detailed_description>Obstructive sleep apnea ( OSA ) characterize repeat occurrence apnea reduce inspiratory air flow due obstruction upper airway ( hypopnea ) . These recur event accompany intermittent hypoxemia sympathetic activation , lead hemodynamic oscillation include relevant variation pulse wave blood pressure . Thus , OSA associate cardiovascular disease identify independent risk factor hypertension . Direct effect obstructive respiratory event ( obstructive apnea hypopnea ) include change peripheral pulse wave . The latter easily measure finger plethysmography , e.g . use establish pulse oximeter . Certain pulse wave characteristic reaction towards obstructive respiratory event may provide information cardiovascular function thereby help individual cardiovascular risk assessment . Recently , Grote et al . publish concept cardiovascular risk assessment base pulse oximetry pulse wave analysis ( `` ASI '' - Grote et al . 2011 , CHEST ) . The algorithm describe herein able differentiate high low risk patient accord ESH/ESC risk classification ( high risk = 4 5 , low risk 1-3 ) . To end , oxygen saturation measure pulse oximetry , reduction pulse wave amplitude , pulse rate acceleration , pulse propagation time cardiorespiratory couple take account calculate quantitative total risk . A successful OSA therapy apply positive airway pressure ( e.g . CPAP ) normalize sleep-related breathing disturbance thus counterbalance hemodynamic oscillation . This presumably result reduce cardiovascular risk detectable measurable change pulse wave . This study aim evaluate effect analyze single pulse wave parameter , part ASI algorithm . At time , establish risk factor well objective therapy outcome document establish sleep medicine viewpoint .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Sleeprelated breathing disorder apneahypopnea index â‰¥15/h &lt; 30 % central respiratory event ( OSA patient ) Stable optimal medication accord European Society Cardiology guideline ( applicable ) Prior exposure positive airway pressure treatment Atrial fibrillation Facial anomalies injury inhibit proper mask fit Pregnancy and/or lactation Acute lifethreatening illness ( e.g . instable angina pectoris , acute bronchial asthma , heart failure New York Heart Association stage IV , myocardial infarction , exacerbate Chronic obstructive pulmonary disease , malignant tumor require treatment ) Drug alcohol abuse Intake hypnotics/sedatives Any medical , psychological condition impair patient 's ability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Pulse wave analysis</keyword>
</DOC>